INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "ADJUVANTED IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED PNEUMOCOCCAL CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF"

GENEVA, March 24 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2024/058829) for "ADJUVANTED IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED PNEUMOCOCCAL CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF" on Sep 11, 2024. With publication no. WO/2025/057078, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KANEVSKY, Isis (c/o Pfizer Inc.401 N. Middletown RoadPearl River, New York 10965), SURENDRAN, Naveen (c/o Pfizer Inc.401 N. Middletown RoadPearl River, New York 10965)...